KK
RCUS icon

KLP Kapitalforvaltning’s Arcus Biosciences RCUS Stock Holding History

KLP Kapitalforvaltning’s Portfolio RCUS Stock Details RCUS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$417K Buy
19,300
+1,100
+6% +$23.8K ﹤0.01% 1501
2025
Q4 		$434K Sell
18,200
-3,700
-17% -$75.5K ﹤0.01% 1482
2025
Q3 		$298K Hold
21,900
– – ﹤0.01% 1657
2025
Q2 		$178K Buy
21,900
+8,000
+58% +$68.3K ﹤0.01% 1831
2025
Q1 		$109K Hold
13,900
– – ﹤0.01% 1993
2024
Q4 		$207K Buy
+13,900
New +$227K ﹤0.01% 1807

Other funds holding RCUS

GS
Gilead Sciences Foster City, California $2.12B AUM 143.53% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
SCM
Suvretta Capital Management New York $3.92B AUM 86.67% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
WP
Woodline Partners San Francisco, California $26.4B AUM 44.85% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return
SL
Siren LLC Greenwich, Connecticut $3.61B AUM 203.3% 1-Year Est. Return

KLP Kapitalforvaltning's RCUS Position: Q1 2026 in Review

KLP Kapitalforvaltning increased its Arcus Biosciences (RCUS) stake by 6% in Q1 2026, buying an estimated $23.8K and bringing the position to 19,300 shares worth $417K. The position accounts for ﹤0.01% of the portfolio, ranked #1501.

KLP Kapitalforvaltning first reported a position in RCUS in Q4 2024 and has held it in 6 quarters since. The position peaked at $434K in Q4 2025. 210 funds tracked by Wall St. Rank hold RCUS as of Q1 2026.

  • KLP Kapitalforvaltning held 19,300 shares of Arcus Biosciences worth $417K as of Q1 2026.
  • KLP Kapitalforvaltning bought 1,100 Arcus Biosciences shares in Q1 2026, an estimated $23.8K.
  • Arcus Biosciences made up ﹤0.01% of KLP Kapitalforvaltning's portfolio in Q1 2026, its #1501 holding.
  • KLP Kapitalforvaltning first reported a position in Arcus Biosciences in Q4 2024 and has held it in 6 quarters since.
  • KLP Kapitalforvaltning's Arcus Biosciences position peaked at $434K in Q4 2025.
  • 210 funds tracked by Wall St. Rank held Arcus Biosciences as of Q1 2026.

Based on KLP Kapitalforvaltning's 13F filing for Q1 2026, filed 29 Apr 2026.